GlycoNAVI: CheGly (Chemical Glycosylation)
ACT

Cleistetroside-7

ID Compound Name Target Name Species Assay Method Activity Value Conditions DOI
act2280Cleistetroside-7NCI-H460 (nonsmall cell lung cancer)GI50 (μM)0.9310.1021/ml300303g
act2328Cleistetroside-7ADR-R (ovarian cancer)GI50 (μM)0.9210.1021/ml300303g
act2256Cleistetroside-7NCI-H460MIC (μM)16.410.1021/ml300303g
act2352Cleistetroside-7DU-145 (prostate cancer)GI50 (μM)0.7810.1021/ml300303g
act2304Cleistetroside-7SNB-75 (CNS cancer)GI50 (μM)0.5410.1021/ml300303g
act2240Cleistetroside-7E. coli impMIC (μM)>6410.1021/ml300303g
act2340Cleistetroside-7CAKI-1 (renal cancer)GI50 (μM)0.8610.1021/ml300303g
act2292Cleistetroside-7HT-29 (colon cancer)GI50 (μM)0.9110.1021/ml300303g
act2364Cleistetroside-7BT-549 (breast cancer)GI50 (μM)1.0510.1021/ml300303g
act2268Cleistetroside-7SR (leukemia)GI50 (μM)0.9210.1021/ml300303g
act2316Cleistetroside-7SK-MEL-5 (melanoma)GI50 (μM)0.7610.1021/ml300303g
act2232Cleistetroside-7E. coli MG1655MIC (μM)>6410.1021/ml300303g
act2322Cleistetroside-7OVCAR-3 (ovarian cancer)GI50 (μM)0.8410.1021/ml300303g
act2274Cleistetroside-7A549 (nonsmall cell lung cancer)GI50 (μM)0.8010.1021/ml300303g
act2346Cleistetroside-7PC-3 (prostate cancer)GI50 (μM)0.7110.1021/ml300303g
act2248Cleistetroside-7B. subtilis JH642MIC (μM)>6410.1021/ml300303g
act2298Cleistetroside-7SF-539 (CNS cancer)GI50 (μM)0.8010.1021/ml300303g
act2358Cleistetroside-7MCF7 (breast cancer)GI50 (μM)0.8910.1021/ml300303g
act2286Cleistetroside-7HCT-15 (colon cancer)GI50 (μM)0.8210.1021/ml300303g
act2334Cleistetroside-7A498 (renal cancer)GI50 (μM)0.6710.1021/ml300303g
act2262Cleistetroside-7RPMI-8226 (leukemia)GI50 (μM)1.0410.1021/ml300303g
act2310Cleistetroside-7MDA-MB-435 (melanoma)GI50 (μM)0.8810.1021/ml300303g